HRP20181315T1 - Nove signalne sekvence za poboljšanje ekspresije proteina i izlučivanja rekombinantnih enzima i drugih proteina - Google Patents

Nove signalne sekvence za poboljšanje ekspresije proteina i izlučivanja rekombinantnih enzima i drugih proteina

Info

Publication number
HRP20181315T1
HRP20181315T1 HRP20181315TT HRP20181315T HRP20181315T1 HR P20181315 T1 HRP20181315 T1 HR P20181315T1 HR P20181315T T HRP20181315T T HR P20181315TT HR P20181315 T HRP20181315 T HR P20181315T HR P20181315 T1 HRP20181315 T1 HR P20181315T1
Authority
HR
Croatia
Prior art keywords
proteins
extraction
protein expression
signal sequences
new signal
Prior art date
Application number
HRP20181315TT
Other languages
English (en)
Croatian (hr)
Inventor
Hung Do
Original Assignee
Amicus Therapeutics, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicus Therapeutics, Inc. filed Critical Amicus Therapeutics, Inc.
Publication of HRP20181315T1 publication Critical patent/HRP20181315T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002Antibodies with enzymatic activity, e.g. abzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2434Glucanases acting on beta-1,4-glucosidic bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/03Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/036Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01022Alpha-galactosidase (3.2.1.22)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01045Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20181315TT 2010-11-22 2011-11-22 Nove signalne sekvence za poboljšanje ekspresije proteina i izlučivanja rekombinantnih enzima i drugih proteina HRP20181315T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41592610P 2010-11-22 2010-11-22
PCT/US2011/061862 WO2012071422A2 (en) 2010-11-22 2011-11-22 Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins
EP11843849.8A EP2643468B1 (en) 2010-11-22 2011-11-22 Novel signal sequences to improve protein expressions and secretion of recombinant enzymes and other proteins

Publications (1)

Publication Number Publication Date
HRP20181315T1 true HRP20181315T1 (hr) 2018-10-19

Family

ID=46146394

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181315TT HRP20181315T1 (hr) 2010-11-22 2011-11-22 Nove signalne sekvence za poboljšanje ekspresije proteina i izlučivanja rekombinantnih enzima i drugih proteina

Country Status (19)

Country Link
US (1) US9279007B2 (cg-RX-API-DMAC7.html)
EP (2) EP3461905B1 (cg-RX-API-DMAC7.html)
JP (1) JP2014503198A (cg-RX-API-DMAC7.html)
KR (2) KR101984318B1 (cg-RX-API-DMAC7.html)
CN (1) CN103328649B (cg-RX-API-DMAC7.html)
BR (1) BR112013012671B1 (cg-RX-API-DMAC7.html)
CA (1) CA2818689C (cg-RX-API-DMAC7.html)
CY (1) CY1121049T1 (cg-RX-API-DMAC7.html)
DK (2) DK3461905T3 (cg-RX-API-DMAC7.html)
ES (2) ES2829199T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20181315T1 (cg-RX-API-DMAC7.html)
HU (1) HUE039070T2 (cg-RX-API-DMAC7.html)
LT (1) LT2643468T (cg-RX-API-DMAC7.html)
PL (1) PL2643468T3 (cg-RX-API-DMAC7.html)
PT (1) PT2643468T (cg-RX-API-DMAC7.html)
RS (1) RS57601B1 (cg-RX-API-DMAC7.html)
SI (1) SI2643468T1 (cg-RX-API-DMAC7.html)
SM (1) SMT201800466T1 (cg-RX-API-DMAC7.html)
WO (1) WO2012071422A2 (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3164492B1 (en) * 2014-07-03 2019-10-23 F. Hoffmann-La Roche AG Polypeptide expression systems
EP3443001B1 (en) 2016-04-11 2025-04-30 Obsidian Therapeutics, Inc. REGULATED BIOCIRCUIT SYSTEMS
MY198804A (en) 2017-06-07 2023-09-28 Regeneron Pharma Compositions and methods for internalizing enzymes
CN111936624A (zh) * 2017-11-30 2020-11-13 阿米库斯治疗学公司 Cdkl5表达变体和cdkl5融合蛋白
BR112020016005A2 (pt) 2018-02-07 2020-12-15 Regeneron Pharmaceuticals, Inc. Método de administração de uma proteína terapêutica ao sistema nervoso central, proteína terapêutica multidomínio, polinucleotídeo, vetor de terapia gênica, e, uso de um nucleotídeo que codifica a proteína terapêutica multidomínio
TWI808169B (zh) 2018-04-30 2023-07-11 美商阿米庫斯醫療股份有限公司 基因治療構築體及使用方法
CN112135624B (zh) 2018-05-17 2024-07-19 瑞泽恩制药公司 抗cd63抗体、缀合物和其用途
EP3806888B1 (en) 2018-06-12 2024-01-31 Obsidian Therapeutics, Inc. Pde5 derived regulatory constructs and methods of use in immunotherapy
CA3115944A1 (en) 2018-10-10 2020-04-16 Amicus Therapeutics, Inc. Disulfide bond stabilized polypeptide compositions and methods of use
WO2020086742A1 (en) 2018-10-24 2020-04-30 Obsidian Therapeutics, Inc. Er tunable protein regulation
CN120519489A (zh) * 2018-12-19 2025-08-22 维萨梅布有限公司 编码蛋白质的rna
CA3132840A1 (en) 2019-03-08 2020-09-17 Obsidian Therapeutics, Inc. Human carbonic anhydrase 2 compositions and methods for tunable regulation
AU2020266829A1 (en) * 2019-04-30 2021-11-11 The Trustees Of The University Of Pennsylvania Compositions useful for treatment of Pompe disease
WO2020252404A1 (en) 2019-06-12 2020-12-17 Obsidian Therapeutics, Inc. Ca2 compositions and methods for tunable regulation
CN114450308A (zh) 2019-06-12 2022-05-06 黑曜石疗法公司 用于调节性调控的ca2组合物和方法
US20220348937A1 (en) 2019-09-06 2022-11-03 Obsidian Therapeutics, Inc. Compositions and methods for dhfr tunable protein regulation
CN112342247B (zh) * 2020-11-10 2022-03-11 江苏科技大学 一种提高家蚕细胞表达外源蛋白分泌率的方法
EP4255500A1 (en) 2020-12-01 2023-10-11 The Trustees of The University of Pennsylvania Compositions and uses thereof for treatment of angelman syndrome
WO2023086939A1 (en) 2021-11-12 2023-05-19 Amicus Therapeutics, Inc. Compositions and methods for treating mucopolysaccharidosis iiia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4892132B2 (ja) * 1998-11-24 2012-03-07 ブリストル−マイヤーズ スクイブ カンパニー 70kD熱ショック蛋白による化合物の細胞内標的輸送
EP1689766B1 (en) * 2003-11-06 2012-04-25 Danisco US Inc. Expression in filamentous fungi of protease inhibitors and variants thereof
US20100222554A1 (en) * 2006-04-11 2010-09-02 Thomas Weimer Method of Increasing the In Vivo Recovery of Therapeutic Polypeptides

Also Published As

Publication number Publication date
CA2818689A1 (en) 2012-05-31
WO2012071422A3 (en) 2012-08-02
EP2643468A2 (en) 2013-10-02
BR112013012671B1 (pt) 2022-03-03
ES2829199T3 (es) 2021-05-31
LT2643468T (lt) 2018-09-10
CY1121049T1 (el) 2019-12-11
PL2643468T3 (pl) 2018-11-30
US20140045216A1 (en) 2014-02-13
EP2643468A4 (en) 2014-12-24
JP2014503198A (ja) 2014-02-13
CN103328649A (zh) 2013-09-25
PT2643468T (pt) 2018-10-11
DK3461905T3 (da) 2020-11-02
SI2643468T1 (sl) 2018-10-30
EP3461905B1 (en) 2020-08-05
HUE039070T2 (hu) 2018-12-28
EP3461905A1 (en) 2019-04-03
CN103328649B (zh) 2016-06-22
BR112013012671A2 (pt) 2016-10-11
SMT201800466T1 (it) 2018-11-09
US9279007B2 (en) 2016-03-08
DK2643468T3 (en) 2018-09-24
WO2012071422A2 (en) 2012-05-31
EP2643468B1 (en) 2018-07-04
KR101984318B1 (ko) 2019-05-31
RS57601B1 (sr) 2018-11-30
KR20130121878A (ko) 2013-11-06
CA2818689C (en) 2021-09-21
KR20190060888A (ko) 2019-06-03
ES2687415T3 (es) 2018-10-25

Similar Documents

Publication Publication Date Title
HRP20181315T1 (hr) Nove signalne sekvence za poboljšanje ekspresije proteina i izlučivanja rekombinantnih enzima i drugih proteina
EP2553102A4 (en) HIGH PERFORMANCE EXPRESSION OF RECOMBINANT TOXIN PROTEINS
EP2547771A4 (en) PREPARATION OF PROTEINS AND POLYPEPTIDES
EP2408921A4 (en) MODIFICATION OF CXCR4 USING MODIFIED ZINC FINGER PROTEINS
EP2426200A4 (en) PROTEIN ELECTRON MEDIATOR
HRP20181154T8 (hr) Konjugati antitijela i lijeka (adc) koji se vežu za 191p4d12 proteine
CO7020851A2 (es) Proteínas y péptidos modificados
BRPI1015350A2 (pt) anticorpos de anti-ceacam1 e métodos de usar os mesmos
LT3040424T (lt) Modifikuoti baltymai ir jų gavimo ir panaudojimo būdai
BR112013014457A2 (pt) método com base em mgmt para obter alta produção de expressão de proteína recombinante
EA201171494A1 (ru) Миметики белка smac
SMT201600033B (it) COMPOSIZIONI E METODI RELATIVI A VARIANTI DELLA PROTEINA A (SpA)
SMT201600314B (it) Coniugati di proteina di coagulazione di sangue
EP2566346A4 (en) PREPARATION OF SOLUBLE PROTEIN SOLUTIONS FROM PULSES
HRP20170983T1 (hr) Pripravci s visokom koncentracijom antitijela
PL3756657T3 (pl) Preparaty peptydu n-końcowego aneksyny a1 i sposoby
EP2563435A4 (en) ADMINISTRATION OF ULTRA PURE NITROGEN MONOXIDE (NO)
BR112013019677A2 (pt) composições nutricionais altamente protéicas e métodos de fazer e usar as mesmas
EP2566333A4 (en) IDENTIFICATION OF STABILIZERS OF MULTIMEDER PROTEINS
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
IL232645B (en) Recombinant proteins and their therapeutic uses
SMT201600147B (it) Metodi per migliorare l'espressione di proteine ricombinanti
EA201792608A3 (ru) Применение белков p3 бактериофага в качестве агентов, связывающих амилоид
EP2742153A4 (en) PROTEIN AND PEPTIDE LIBRARIES
DK2547694T5 (da) Hidtil ukendt signalpeptid og anvendelse deraf til fremstilling af rekombinante proteiner